Singapore markets open in 1 hour 36 minutes

Biora Therapeutics, Inc. (PROG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8845-0.0318 (-3.47%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.9163
Bid0.0000 x 900
Ask0.0000 x 1400
Day's range0.8400 - 0.9200
52-week range0.6301 - 6.2000
Avg. volume6,627,567
Market cap162.924M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Shares of Progenity Are Down More Than 11% on Wednesday

    Progenity (NASDAQ: PROG), a biotech company and a meme stock favorite, saw its shares decline more than 11% on Wednesday. Overall, Progenity stock is down more than 47% this year. The markets don't like uncertainty, and that's one reason Progenity has trended downward.

  • Motley Fool

    Why Progenity Stock Is Up More Than 34% Tuesday

    Shares of Progenity (NASDAQ: PROG) were up more than 34% on Tuesday. At the time of its initial public offering in 2020, the biotech company went for $13 a share, and the stock has been highly volatile because it is a retail investor favorite. It is the second time in less than a month that Progenity has taken off on a short-squeeze-fueled frenzy.

  • Zacks

    Progenity, Inc. (PROG) Reports Q3 Loss, Lags Revenue Estimates

    Progenity, Inc. (PROG) delivered earnings and revenue surprises of 19.15% and -98.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?